Maharashtra reported a significant rise in Chikungunya cases, increasing from 473 in early 2024 to 658 by April 2025. While other vector-borne diseases like malaria and dengue show a downward trend, ...

Pune: There were concerning complications seen in children during last year's chikungunya outbreak, including one case which ...

Copenhagen, Denmark Saturday, May 3, 2025, 12:00 Hrs [IST] ...

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorisation to Bavarian Nordic's ...

The Medicines and Healthcare products Regulatory Agency (MHRA) yesterday approved Vimkunya, a vaccine used to prevent disease caused by the chikungunya virus in people 12 years of age and older. The ...

VIMKUNYA is a single dose, prefilled, adjuvanted VLP recombinant protein vaccine for active immunization for the prevention ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has today (1 May 2025) approved a vaccine (Vimkunya) used to ...

Recommendations for the use of chikungunya vaccine were recently discussed at a meeting of the Advisory Committee on Immunization Practices.

UK Health Security Agency said diseased from holidaymakers coming back from breaks at some of the biggest destinations have ...